For how we live.
In 374 adults with drug-resistant focal epilepsy, the 25 mg dose of azetukalner more than halved monthly seizures versus placebo over 12 weeks — one trial of a drug that is not yet approved.
A meta-analysis of 86 population-based studies estimated that about 236 infants per 100,000 live births develop epilepsy in the first two years, with developmental encephalopathies the largest share.
In the MONEAD cohort, six-year-olds whose mothers breastfed while taking antiseizure medicines scored no worse on language or adaptive behaviour — and longer breastfeeding tracked with slightly better scores.
A Spanish registry followed 166 patients with treatment-resistant epileptic encephalopathies for a year. Median seizure frequency fell 68.8%, though the design cannot match a placebo-controlled trial.
Wrist and body sensors detect roughly 9 in 10 tonic-clonic seizures. A 192-patient validation against video-EEG found the harder focal seizures still slip past, or bury the alarm in false alerts.
A WHO data-set analysis shows how mobile and hospital teams split the load of hypertension, diabetes and epilepsy care during the war, while a separate study tracked dialysis capacity falling.
A Norwegian study of 204,663 children found no raised risk of autism or most neurodevelopmental disorders after maternal COVID in pregnancy — with one exception in the early pandemic.
ETX101 doesn't replace the faulty gene behind Dravet syndrome — it turns up the healthy copy that's still there. New data from 21 children show the effect holding for a year.